PERISPLENITIS

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting PERISPLENITIS:

# Drug Count
0 AMBRISENTAN 1
1 AZACITIDINE 1
2 AZACITIDINE FOR 1
3 PEGFILGRASTIM-CBQV 1
4 VENETOCLAX 1
See all common drugs associated with PERISPLENITIS

PERISPLENITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGFILGRASTIM-CBQV 1 0.0007
1 AZACITIDINE 1 0.0000
2 VENETOCLAX 1 0.0000
3 AMBRISENTAN 1 0.0000
See all drugs enriched for association with PERISPLENITIS

These drug classes are most commonly taken by patients reporting PERISPLENITIS:

# Drug class Count
0 BCL-2 Inhibitor [EPC] 1
1 Endothelin Receptor Antagonist [EPC] 1
2 Leukocyte Growth Factor [EPC] 1
3 Nucleoside Metabolic Inhibitor [EPC] 1
See all common drug classes associated with PERISPLENITIS

PERISPLENITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 1 0.0000
1 Leukocyte Growth Factor [EPC] 1 0.0000
2 Endothelin Receptor Antagonist [EPC] 1 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with PERISPLENITIS